AMGEN INC
AMGNAPI behind this page
AMGN Q1 2026 request
Playground key active
/api/financials?ticker=AMGN&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 8,618 | 8,149 | +5.8% |
Show Product Lines breakouts |
|||
| Aranesp | 311 | 340 | -8.5% |
| Aranesp · Non Us | 234 | 249 | -6.0% |
| Aranesp · US | 77 | 91 | -15.4% |
| BLINCYTO | 415 | 370 | +12.2% |
| BLINCYTO · Non Us | 194 | 97 | +100.0% |
| BLINCYTO · US | 221 | 273 | -19.0% |
| ENBREL | 320 | 510 | -37.3% |
| ENBREL · Non Us | 6 | 6 | 0.0% |
| ENBREL · US | 314 | 504 | -37.7% |
| EVENITY | 562 | 442 | +27.1% |
| EVENITY · Non Us | 131 | 122 | +7.4% |
| EVENITY · US | 431 | 320 | +34.7% |
| IMDELLTRA/IMDYLLTRA | 258 | 81 | +218.5% |
| IMDELLTRA/IMDYLLTRA · Non Us | 70 | 2 | +3400.0% |
| IMDELLTRA/IMDYLLTRA · US | 188 | 79 | +138.0% |
| KRYSTEXXA | 255 | 236 | +8.1% |
| KRYSTEXXA · US | 255 | 236 | +8.1% |
| KYPROLIS | 330 | 324 | +1.9% |
| KYPROLIS · Non Us | 112 | 108 | +3.7% |
| KYPROLIS · US | 218 | 216 | +0.9% |
| Nplate | 412 | 313 | +31.6% |
| Nplate · Non Us | 129 | 112 | +15.2% |
| Nplate · US | 283 | 201 | +40.8% |
| Otezla | 431 | 437 | -1.4% |
| Otezla · Non Us | 79 | 94 | -16.0% |
| Otezla · US | 352 | 343 | +2.6% |
| Other products | 1,528 | 1,475 | +3.6% |
| Other products · Non Us | 397 | 366 | +8.5% |
| Other products · US | 1,131 | 1,109 | +2.0% |
| Product | 8,218 | 7,873 | +4.4% |
| Product And Service Other | 400 | 276 | +44.9% |
| Product And Service Other · Reportable Segment | 400 | 276 | +44.9% |
| Product · Accumulated Gain Loss Net Cash Flow Hedge Parent | -36 | 56 | -164.3% |
| Product · Accumulated Gain Loss Net Cash Flow Hedge Parent | -36 | 56 | -164.3% |
| Product · Non Us | 2,445 | 2,211 | +10.6% |
| Product · Reportable Segment | 8,218 | 7,873 | +4.4% |
| Product · US | 5,773 | 5,662 | +2.0% |
| Prolia | 727 | 1,099 | -33.8% |
| Prolia · Non Us | 266 | 379 | -29.8% |
| Prolia · US | 461 | 720 | -36.0% |
| Repatha | 876 | 656 | +33.5% |
| Repatha · Non Us | 411 | 313 | +31.3% |
| Repatha · US | 465 | 343 | +35.6% |
| TEPEZZA | 490 | 381 | +28.6% |
| TEPEZZA · Non Us | 66 | 16 | +312.5% |
| TEPEZZA · US | 424 | 365 | +16.2% |
| TEZSPIRE | 343 | 285 | +20.4% |
| TEZSPIRE · US | 343 | 285 | +20.4% |
| UPLIZNA | 262 | 91 | +187.9% |
| UPLIZNA · Non Us | 16 | 9 | +77.8% |
| UPLIZNA · US | 246 | 82 | +200.0% |
| Vectibix | 287 | 267 | +7.5% |
| Vectibix · Non Us | 151 | 132 | +14.4% |
| Vectibix · US | 136 | 135 | +0.7% |
| XGEVA | 411 | 566 | -27.4% |
| XGEVA · Non Us | 183 | 206 | -11.2% |
| XGEVA · US | 228 | 360 | -36.7% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 8,618 | 8,149 | +5.8% |
| Cost of Revenue | 2,744 | 2,968 | -7.5% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 2,180 | 2,528 | -13.8% |
| Research And Development Expense Excluding Acquired In Process Cost | 1,719 | 1,486 | +15.7% |
| Selling, General & Administrative | 1,602 | 1,687 | -5.0% |
| Other Nonrecurring Income Expense | -113 | 830 | -113.6% |
| Total Costs & Expenses | 5,952 | 6,971 | -14.6% |
| Operating Income | 2,666 | 1,178 | +126.3% |
| Interest Expense Debt | -657 | -723 | +9.1% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | -657 | -723 | +9.1% |
| Non-Operating Income (Expense) | 75 | 1,518 | -95.1% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Cross-currency swap contracts | -77 | 83 | -192.8% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Cross-currency swap contracts | -77 | 83 | -192.8% |
| Income Before Taxes | 2,084 | 1,973 | +5.6% |
| Income Tax Expense (Benefit) | 265 | 243 | +9.1% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 265 | 243 | +9.1% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | -24 | 30 | -180.0% |
| Net Income | 1,819 | 1,730 | +5.1% |
Show Business Segments breakouts |
|||
| Reportable Segment | 1,819 | 1,730 | +5.1% |
| Reportable Segment · Operating Segments | 1,819 | 1,730 | +5.1% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | -89 | 109 | -181.7% |
| Retained Earnings | 1,819 | 1,730 | +5.1% |
| EPS (Basic) | 3.37 | 3.22 | +4.7% |
| EPS (Diluted) | 3.34 | 3.2 | +4.4% |
| Wtd Avg Shares (Basic) | 540 | 538 | +0.4% |
| Wtd Avg Shares (Diluted) | 544 | 541 | +0.6% |
| Sales & Marketing (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 1,134 | 1,066 | +6.4% |
| General & Administrative (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 468 | 621 | -24.6% |
| Interest Income | 101 | 126 | -19.8% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 101 | 126 | -19.8% |
| Comprehensive Income | 1,887 | 1,565 | +20.6% |
| Other Comprehensive Income | 68 | -165 | +141.2% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 68 | -165 | +141.2% |
| Depreciation And Amortization | 220 | 209 | +5.3% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | -113 | 139 | -181.3% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 12,038 | 8,810 | +36.6% |
| Accounts Receivable | 9,138 | 8,132 | +12.4% |
| Inventory | 6,186 | 6,729 | -8.1% |
| Other Assets Current | 4,113 | 3,258 | +26.2% |
| Total Current Assets | 31,475 | 26,929 | +16.9% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 8,216 | 6,681 | +23.0% |
| Goodwill | 18,674 | 18,645 | +0.2% |
| Other Non-Current Assets | 12,760 | 11,388 | +12.0% |
| Total Assets | 92,504 | 89,367 | +3.5% |
| Intangible Assets | 20,669 | 24,664 | -16.2% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Developed Technology Rights | 20,194 | 24,081 | -16.1% |
| Licensing Agreements | 363 | 450 | -19.3% |
| Research and development technology rights | 112 | 133 | -15.8% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 21,379 | 25,724 | -16.9% |
| Current Liabilities | |||
| Accounts Payable | 2,935 | 2,406 | +22.0% |
| Accrued Liabilities | 16,583 | 17,234 | -3.8% |
| Current Portion of Long-Term Debt | 5,437 | 3,368 | +61.4% |
| Total Current Liabilities | 24,955 | 23,008 | +8.5% |
| Non-Current Liabilities | |||
| Long-Term Debt | 51,886 | 54,013 | -3.9% |
| Deferred Tax Liabilities | 1,344 | 1,510 | -11.0% |
| Liability For Uncertain Tax Positions Noncurrent | 2,764 | 2,419 | +14.3% |
| Other Non-Current Liabilities | 2,365 | 2,210 | +7.0% |
| Long-Term Debt | 57,323 | 57,381 | -0.1% |
Show Long-Term Debt Type breakouts |
|||
| Notes Payable To Banks | 55.5 | 55.6 | -0.2% |
| Stockholders' Equity | |||
| Common Stocks Including Additional Paid In Capital | 34,030 | 33,578 | +1.3% |
| Retained Earnings | -24,650 | -27,140 | +9.2% |
| Accumulated Other Comprehensive Income | -190 | -231 | +17.7% |
| Total Stockholders' Equity | 9,190 | 6,207 | +48.1% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -13 | 64 | -120.3% |
| Accumulated Other Comprehensive Income | -190 | -231 | +17.7% |
| Accumulated Translation Adjustment | -207 | -317 | +34.7% |
| Common Stock Including Additional Paid In Capital | 34,030 | 33,578 | +1.3% |
| Other | 30 | 22 | +36.4% |
| Retained Earnings | -24,650 | -27,140 | +9.2% |
| Total Liabilities & Equity | 92,504 | 89,367 | +3.5% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 1,116 | 1,387 | -19.5% |
| Stock-Based Compensation | 75 | 85 | -11.8% |
| Deferred Income Taxes And Tax Credits | -176 | -250 | +29.6% |
| Unrealized Gain Loss On Investments | 143 | -1,295 | +111.0% |
| Other Non-Cash Items | -67 | -50 | -34.0% |
| Change in Accounts Receivable | 413 | -1,308 | +131.6% |
| Change in Inventory | 18 | 288 | -93.8% |
| Increase Decrease In Other Operating Assets | 8 | -201 | +104.0% |
| Change in Accounts Payable | 571 | 497 | +14.9% |
| Increase Decrease In Accrued Income Taxes Payable | 71 | 104 | -31.7% |
| Increase Decrease In Noncurrent Tax Liability | 71 | 70 | +1.4% |
| Increase Decrease In Accrued Liabilities | -959 | -874 | -9.7% |
| Increase Decrease In Sales Incentives And Allowance | -839 | 486 | -272.6% |
| Increase Decrease In Other Operating Liabilities | -75 | -78 | +3.8% |
| Net Cash from Operations | 2,189 | 1,391 | +57.4% |
| Investing Activities | |||
| Capital Expenditures | -712 | -411 | -73.2% |
| Other Investing Activities | -4 | -36 | +88.9% |
| Net Cash from Investing | -716 | -447 | -60.2% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 3,964 | — | — |
| Payments Of Debt Extinguishment Costs | -233 | -301 | +22.6% |
| Repayments Of Long Term Debt | -833 | -2,500 | +66.7% |
Show Debt Instrument breakouts |
|||
| 2.00% Note Due 2026 · Notes Payable To Banks | -750 | — | — |
| Payments Of Dividends Common Stock | -1,358 | -1,279 | -6.2% |
| Proceeds From Payments For Other Financing Activities | -104 | -27 | -285.2% |
| Net Cash from Financing | 1,436 | -4,107 | +135.0% |
| Other Cash Flow | |||
| Net Change in Cash | 2,909 | -3,163 | +192.0% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 12,038 | 8,810 | +36.6% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.